RCE1 and urinary bladder carcinoma: Face-2 variants were also observed on several human cancers (neuroblastoma cell lines IMR-32 and LAN-1) [14] and on colon [54], breast, ovarian, renal, and bladder carcinoma and human melanoma cell lines [15,16]).